Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10k-ex3101.htm |
| EX-10.7 - STANDARD OFFICE LEASE - Brooklyn ImmunoTherapeutics, Inc. | ntn_10k-ex1007.htm |
| EX-31.2 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10k-ex3102.htm |
| EX-10.25 - LETTER OFFER OF EMPLOYMENT - Brooklyn ImmunoTherapeutics, Inc. | ntn_10k-ex1025.htm |
| EX-23.1 - CONSENT - Brooklyn ImmunoTherapeutics, Inc. | ntn_10k-ex2301.htm |
| EX-10.22 - AMENDED AND RESTATED EMPLOYMENT AGREEMENT - Brooklyn ImmunoTherapeutics, Inc. | ntn_10k-ex1022.htm |
| EX-32.1 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10k-ex3201.htm |
| EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Brooklyn ImmunoTherapeutics, Inc. | ntn_10k-ex2101.htm |
| 10-K - NTN BUZZTIME, INC. - Brooklyn ImmunoTherapeutics, Inc. | ntn_10k-123110.htm |
| EX-10.26 - MASTER EQUIPMENT LEASE - Brooklyn ImmunoTherapeutics, Inc. | ntn_10k-ex1026.htm |
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFIER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of NTN Buzztime, Inc. (the “Registrant”) on Form 10-K for the year ended December 31, 2010, I, Kendra Berger, Chief Financial Officer of the Registrant, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) the Annual Report on Form 10-K of the Registrant for the year ended December 31, 2010, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
Dated: March 25, 2011
|
/s/ KENDRA BERGER
|
|
|
Kendra Berger,
Chief Financial Officer
NTN Buzztime, Inc.
|